热门资讯> 正文
Addex Therapeutics报告H1结果
2024-09-19 22:35
- Addex Therapeutics press release (NASDAQ:ADXN): H1 net gain of CHF 9.8 million.
- The cash position of the Group amounted to CHF 3.8 million as of June 30, 2024.
More on Addex Therapeutics
- Addex stock rallies 45% on Indivior collaboration update
- J&J ends work on Addex epilepsy drug candidate ADX71149: report
- Seeking Alpha’s Quant Rating on Addex Therapeutics
- Historical earnings data for Addex Therapeutics
- Financial information for Addex Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
